• Categories
  • Archives

Brazil Is Back to Square One on Its Dispute with AIDS Drug Maker Abbott

The expensive prices of the HIV/AIDS drugs charged by international laboratories may jeopardize the sustainability of the Brazilian government’s program of universal drug access treatment.

According to Pedro Chequer, director of the Health Ministry’s DST/AIDS Program, the Ministry’s annual per patient expenses for AIDS victims have risen from US$ 1600 in 2001 to US$ 2500 this year.


According to Chequer, if the demand remains the same, the program may face problems four or five years from now.


“Brazil must continue to negotiate with the foreign laboratories that own the patent rights, to manage a price reduction,” he said.


Chequer approves the decision of the new Minister of Health, José Saraiva Felipe, who, right after he took office, reopened negotiations with Abbott Laboratories, owner of the Kaletra (Ritonair/Lopinavir) patent.


“Abbot’s proposal doesn’t interest us. They should present another proposal that has to do with the real necessities and interests of the country.”


According to Chequer, the agreement made by the former Minister, Humberto Costa, despite reducing the prices of Kaletra and giving up the (voluntary licensing) patent-breaking request, is still insatisfactory.


He said that the agreement stipulates that Brazil can buy the drug for US$ 0.99 next year, while the Farmanginhos State Laboratory can manufacture Kalestra for US$ 0.40.


Agência Brasil

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Brazil Workers Party’s Money Man Sues PT to Get His Money Back

Advertising executive Marcos Valério is taking Brazil’s Workers Party (PT) to court to recover ...

Smiles, Misery and Crack in the Favelas of Brazil

When I entered the “favelas” for the first time, I couldn’t believe my eyes. ...

Brazil South Has Already Exported US$ 12 Billion This Year

Brazilian businesses small and medium from the states of Rio Grande do Sul, Santa ...

Brazil to Adopt US Model of Home Care to Deal with Hospitalization Demand

Brazilian president Dilma Rousseff announced that Brazil will use the experience of home care ...

Angra 1 Nuclear Plant

Nuclear Brazil Is Hiding Something. But What?

Secrecy shrouding Brazil’s nuclear capabilities, suspected technological advances and provocative statements made by Luiz ...

Brazil to Propose Preventive Agreements to IMF

Brazil’s Minister of Finance, Antônio Palocci, will participate in the annual meetings of the ...

Brazilian Youth Want Jobs and End to Violence

Around 30% of the Brazilian population is composed of youth between the ages of ...

American pilots Joe Lepore and Jan Paladino

Brazil’s Supreme Says American Pilots Can’t Be Compelled to Testify in Brazil

Ellen Gracie Northfleet, the chief of the Brazilian Supreme Court (STF), told the president ...

Brazil’s State Firm Embrapa Creates 14 Transgenic Species. Seeds Are for Sale.

In a special program, "Soybeans – A Big Business," broadcast on Friday, January 20, ...

Brazil: Starving at Home to Fatten Speculators

The Brazilian economy continues to be the cave of Ali Baba transformed into a ...